These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26577223)

  • 1. Cholesterol absorption and synthesis markers in Portuguese hypercholesterolemic adults: A cross-sectional study.
    Andrade I; Santos L; Ramos F
    Eur J Intern Med; 2016 Mar; 28():85-90. PubMed ID: 26577223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects.
    Niesor EJ; Chaput E; Staempfli A; Blum D; Derks M; Kallend D
    Atherosclerosis; 2011 Dec; 219(2):761-7. PubMed ID: 21982411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coronary artery calcium score is linked to plasma cholesterol synthesis and absorption markers: Brazilian Longitudinal Study of Adult Health.
    Nunes VS; Bensenor IM; Lotufo PA; Passarelli M; Nakandakare ER; Quintão ECR
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32579186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
    Hedman M; Miettinen TA; Gylling H; Ketomäki A; Antikainen M
    J Pediatr; 2006 Feb; 148(2):241-6. PubMed ID: 16492436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus.
    Okada K; Yagyu H; Kotani K; Miyamoto M; Osuga J; Nagasaka S; Ishibashi S
    Endocr J; 2010; 57(10):903-8. PubMed ID: 20733267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anagliptin decreases serum lathosterol level in patients with type 2 diabetes: a pilot study.
    Aoki K; Ijima T; Kamiyama H; Kamiko K; Terauchi Y
    Expert Opin Pharmacother; 2015; 16(12):1749-54. PubMed ID: 26098722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study.
    Miettinen TA; Hallikainen M; Raitakari OT; Viikari J; Gylling H
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):525-31. PubMed ID: 19185477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men.
    Nissinen MJ; Miettinen TE; Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):308-16. PubMed ID: 19695854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal Variation of Markers for Cholesterol Synthesis, Cholesterol Absorption, and Bile Acid Synthesis: A Systematic Review and the Bispebjerg Study of Diurnal Variations.
    Schroor MM; Sennels HP; Fahrenkrug J; Jørgensen HL; Plat J; Mensink RP
    Nutrients; 2019 Jun; 11(7):. PubMed ID: 31247945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial.
    Matthan NR; Resteghini N; Robertson M; Ford I; Shepherd J; Packard C; Buckley BM; Jukema JW; Lichtenstein AH; Schaefer EJ;
    J Lipid Res; 2010 Jan; 51(1):202-9. PubMed ID: 19578163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women.
    Rajaratnam RA; Gylling H; Miettinen TA
    J Am Coll Cardiol; 2000 Apr; 35(5):1185-91. PubMed ID: 10758959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial behavior of plasma squalene and non-cholesterol sterols in men with varying cholesterol absorption.
    Hallikainen M; Vidgren H; Agren JJ; Kiviniemi V; Miettinen TA; Gylling H
    Clin Chim Acta; 2006 Dec; 374(1-2):63-8. PubMed ID: 16814761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD.
    Matthan NR; Pencina M; LaRocque JM; Jacques PF; D'Agostino RB; Schaefer EJ; Lichtenstein AH
    J Lipid Res; 2009 Sep; 50(9):1927-35. PubMed ID: 19436064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject.
    Ketomaki A; Gylling H; Miettinen TA
    J Lab Clin Med; 2004 Apr; 143(4):255-62. PubMed ID: 15085084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-cholesterol sterols in different forms of primary hyperlipemias.
    Lupattelli G; Pirro M; Siepi D; Mannarino MR; Roscini AR; Vaudo G; Pasqualini L; Schillaci G; Mannarino E
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):231-6. PubMed ID: 20708389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of β-cryptoxanthin plus phytosterols on cardiovascular risk and bone turnover markers in post-menopausal women: a randomized crossover trial.
    Granado-Lorencio F; Lagarda MJ; Garcia-López FJ; Sánchez-Siles LM; Blanco-Navarro I; Alegría A; Pérez-Sacristán B; Garcia-Llatas G; Donoso-Navarro E; Silvestre-Mardomingo RA; Barberá R
    Nutr Metab Cardiovasc Dis; 2014 Oct; 24(10):1090-6. PubMed ID: 24909799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.
    van Himbergen TM; Otokozawa S; Matthan NR; Schaefer EJ; Buchsbaum A; Ai M; van Tits LJ; de Graaf J; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):113-20. PubMed ID: 19834104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol metabolism in cardiac sarcoidosis.
    Simonen P; Lehtonen J; Gylling H; Kupari M
    Atherosclerosis; 2016 May; 248():210-5. PubMed ID: 27035112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.